D-1339-2019 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- June 19, 2019
- Initiation Date
- May 23, 2019
- Termination Date
- February 5, 2021
- Voluntary/Mandated
- FDA Mandated
- Product Quantity
- 4 vials
Product Description
Trimix 30mg/1 mg/10mcg/mL ( 30 mg Papaverine, 1mg phentolamine mesylate, 30 mcg alprostadil) Injectable, 5mL vials, Rx only, Pharm D. Solutions 1304 South Loop West, Houston, TX 77054, 1-844-263-6846
Reason for Recall
Lack of Sterility Assurance.
Distribution Pattern
Nationwide within the United States
Code Information
Lot #: 05022019:90 Exp. 07/13/2019